NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00158652,Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC,https://clinicaltrials.gov/study/NCT00158652,,COMPLETED,This is a multicentric randomized phase III trial comparing conventional radiotherapy with concomitant chemotherapy versus accelerated radiotherapy with concomitant chemotherapy versus very accelerated radiotherapy in patients with stage III-IV head and neck squamous cell carcinoma. The main end point is the event free survival.,NO,Oral Cancer|Oropharynx Cancer|Hypopharynx Cancer|Larynx Cancer,"PROCEDURE: Conventional radiotherapy 70 Gy in 7 weeks|PROCEDURE: middle accelerated radiotherapy 70 Gy in 6 weeks|PROCEDURE: very accelerated radiotherapy 64.8 Gy in 3.5 weeks|DRUG: 5FU, Paraplatin","Event free survival (event=progression, relapse, death from any cause), 3 years","Survival, 3 years|Loco regional control, 3 years|Toxicity, early and late",,Groupe Oncologie Radiotherapie Tete et Cou,,ALL,"ADULT, OLDER_ADULT",PHASE3,840,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,GORTEC 99-02,2000-03,2011-03,2011-03,2005-09-12,,2011-11-08,"CHU de Tours, Tours, 37 044, France|Institut Gustave Roussy, Villejuif, 94800, France",
